InvestorsHub Logo
Followers 56
Posts 5540
Boards Moderated 0
Alias Born 11/04/2011

Re: RJFL post# 54962

Sunday, 02/23/2014 5:02:57 PM

Sunday, February 23, 2014 5:02:57 PM

Post# of 403092
I don't think this is Kevetrin. The study title is different. Kevetrin's study title should be:

"A Multi-Center, Open-Labe, Phase 1B Study of Escalating Doses of Kevetrin (Thioureidobutyronitrile) Administered Intravenously, with Cytarabine Adminstered A) Subcutaneously, or B) Intravenously, in Patients with Acute Myelogenous Leukemia (AML)"
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News